Friday, March 22, 2013- 4 Healthcare Stock Stories To Close the Trading Weekat Wall St. Cheat Sheet (Fri, Mar 22)
- Biogen’s Revolutionary Multiple Sclerosis Treatment Clears First Hurdleat Motley Fool (Fri, Mar 22)
- Biogen’s Tecfidera MS Drug Wins EU Agency’s Backingat Bloomberg (Fri, Mar 22)
- Biogen's Plegridy Records Strong First-Year Clinical Resultsat Motley Fool (Fri, Mar 22)
- Biogen, Baxter, Sanofi, Gilead Win EU Endorsementsat Investor's Business Daily (Fri, Mar 22)
- Sanofi Obtains EU Panel Recommendation for MS Tablet Aubagioat Bloomberg (Fri, Mar 22)
- More Protection for Biogen's TecfideraZacks (Fri, Mar 22)
- UPDATE 1-EU backs MS drugs from Biogen, Sanofi; Gilead HIV pillat Reuters (Fri, Mar 22)
- CHMP Issues Positive Opinion for TECFIDERA™ (Dimethyl Fumarate) as a First-Line Treatment for Multiple Sclerosis in the European UnionBusiness Wire (Fri, Mar 22)
- EU agency backs new MS drugs from Biogen and Sanofiat Reuters (Fri, Mar 22)
Thursday, March 21, 2013 Wednesday, March 20, 2013- Cramer's 6 Stocks in 60 Seconds: WAG APC ZNGA BIIB CTAS SWKS (Update 1)at TheStreet (Wed, Mar 20)
- 4 Healthcare Stock Stories Prescribed for Investorsat Wall St. Cheat Sheet (Wed, Mar 20)
- Biogen Idec Stock Hits New 52-Week High (BIIB)at TheStreet (Wed, Mar 20)
- Analysts: Apple May Lose Smartphone Share and 4 New Opinions Investors Must Read Nowat Wall St. Cheat Sheet (Wed, Mar 20)
- [video] Cramer's Six in 60: Walgreen a 'Game Changer'at CNBC (Wed, Mar 20)
- HFF Inc. Director Sells 90K Shares and 4 Insider Sales to Noteat Wall St. Cheat Sheet (Wed, Mar 20)
- Positive Year One Results from Biogen Idec Phase 3 ADVANCE Trial of PLEGRIDY™ (Peginterferon Beta-1a) Presented at AAN MeetingBusiness Wire (Wed, Mar 20)
- Biogen's injectable MS drug cut relapse rate by 36 pctat Reuters (Wed, Mar 20)
- Biogen, HTC, Boston, MIT, Mary Bono: Intellectual Propertyat Bloomberg (Wed, Mar 20)
Tuesday, March 19, 2013Add BIIB News to My Yahoo!   | |
|
0.80%